Avantax Advisory Services’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$343K Sell
14,919
-120
-0.8% -$2.78K ﹤0.01% 1816
2025
Q1
$338K Buy
15,039
+2,474
+20% +$57.5K ﹤0.01% 1753
2024
Q4
$246K Sell
12,565
-1,464
-10% -$29K ﹤0.01% 1924
2024
Q3
$255K Sell
14,029
-688
-5% -$13.1K ﹤0.01% 1871
2024
Q2
$256K Buy
+14,717
New +$261K ﹤0.01% 1804

Other funds holding PRVA

Avantax Advisory Services's PRVA Position: Q2 2025 in Review

Avantax Advisory Services reduced its Privia Health (PRVA) stake by 0.8% in Q2 2025, selling an estimated $2.78K and leaving 14,919 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #1816.

Avantax Advisory Services first reported a position in PRVA in Q2 2024 and has held it in 5 quarters since. 280 funds tracked by Wall St. Rank hold PRVA as of Q2 2025.

  • Avantax Advisory Services held 14,919 shares of Privia Health worth $343K as of Q2 2025.
  • Avantax Advisory Services sold 120 Privia Health shares in Q2 2025, an estimated $2.78K.
  • Privia Health made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1816 holding.
  • Avantax Advisory Services first reported a position in Privia Health in Q2 2024 and has held it in 5 quarters since.
  • 280 funds tracked by Wall St. Rank held Privia Health as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.